New Injectable Approved for a Type of Kidney Disease

(MedPage Today) — The FDA granted accelerated approval to sibeprenlimab injection (Voyxact) for the reduction of proteinuria in adults with primary immunoglobulin A (IgA) nephropathy at risk for disease progression, the agency announced on Tuesday…

Source link : https://www.medpagetoday.com/nephrology/generalnephrology/118740

Author :

Publish date : 2025-11-26 16:44:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

New Injectable Approved for a Type of Kidney Disease

In IgA Nephropathy, Knowing the Data Matters in Shared Decision-Making

Time to Retire the Term ‘Metabolically Healthy Obesity’?

Related Posts

Investigational Oral Drug Shows Promise in Genetic Bleeding Disorder

Driving Patterns May Signal Early Cognitive Trouble

Is Chronic Cough Another Side Effect of GLP-1 Drugs?

As MAHA Expands Its Reach, Some Critics Hear Echoes of the Eugenics Movement

Medicare Rule on Outpatient, Ambulatory Surgical Center Rates Gets Divided Reactions

Easter Island statues may have been built by small independent groups

Investigational Oral Drug Shows Promise in Genetic Bleeding Disorder

Driving Patterns May Signal Early Cognitive Trouble

Is Chronic Cough Another Side Effect of GLP-1 Drugs?

As MAHA Expands Its Reach, Some Critics Hear Echoes of the Eugenics Movement

Medicare Rule on Outpatient, Ambulatory Surgical Center Rates Gets Divided Reactions

Easter Island statues may have been built by small independent groups

A Two-Step PCI for Blocked Arteries: Does Timing Matter?

Cold-water swimming has benefits for the brain as well as the body

Categories

Archives